The global C-reactive protein (CRP) testing market is valued at USD 5.58 billion in 2024, expected to reach USD 5.75 billion by 2034, growing at a CAGR of 0.3%. Key drivers include rising inflammation cases, technological advancements, and the demand for point-of-care diagnostics.
The global facial feminization surgery (FFS) market is experiencing robust growth, projected to reach hundreds of millions USD by 2034,… Read More
The global chronic disease treatment market is experiencing robust growth. Valued at USD 8.37 billion in 2024, the market is… Read More
The Generative AI in Drug Discovery market is experiencing an unprecedented surge, driven by its transformative potential in accelerating drug… Read More
The global Drug Discovery as a Service market is witnessing rapid expansion, fueled by advancements in AI, machine learning, and… Read More
The drug discovery SaaS platforms market is poised for significant growth between 2025 and 2035, with projections estimating revenues reaching… Read More
The Computer-Aided Drug Design (CADD) market is witnessing remarkable growth globally, driven by rising R&D investments, increasing demand for efficient… Read More